Mutations in ENG and ACVRL1 lead to HHT Type 1 and 2, respectively, while SMAD4 mutations result in a combined juvenile polyposis-HHT syndrome (JP/HHT). The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.